ITRI vs PATH
Itron Inc (ITRI) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Itron Inc (ITRI) is a scientific & technical instruments company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ITRI revenue for 2024-12-31 was $2.44B. Net income was $241.1M. Revenue was up 12.3% from 2023-12-31 to 2024-12-31. ITRI currently screens at market cap $3.64B and trailing P/E 13.1.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ITRI currently screens at market cap $3.64B and trailing P/E 13.1. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ITRI and PATH stock pages for the full models.
Not investment advice.